Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Tes And Slc40a1 As Potential Biomarkers For Predicting Survival In T-cell Acute Lymphoblastic Leukemia.
  1. Home
  3. Tes And Slc40a1 As Potential Biomarkers For Predicting Survival In T-cell Acute Lymphoblastic Leukemia.

Related Experiment Video

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.0K

TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia.

Xiangyou Zeng1,2, Kaifan Liu1,2, Ruohao Xu1,2

  • 1Department of Hematology, School of Medicine, South China University of Technology, Guangzhou, China.

Acta Haematologica
|May 28, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Identifying prognostic biomarkers for T-cell acute lymphoblastic leukemia (T-ALL) is vital. This study found that TES and SLC40A1 gene expression levels can predict survival outcomes in T-ALL patients, aiding personalized therapy.

Keywords:
Differentially expressed genesFunctional enrichment analysisSurvival predictionT-cell acute lymphoblastic leukemiaTranscriptome sequencingUnivariate Cox regression

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

Related Experiment Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.0K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.0K

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Accurate prognosis for T-cell acute lymphoblastic leukemia (T-ALL) is challenging due to a lack of reliable biomarkers.
  • Personalized therapeutic strategies for T-ALL require robust indicators of patient outcomes.

Purpose of the Study:

  • To identify and validate novel gene expression biomarkers for predicting survival in T-ALL patients.
  • To investigate the molecular mechanisms associated with T-ALL prognosis.

Main Methods:

  • Integrated analysis of public gene expression datasets to identify differentially expressed genes (DEGs) in T-ALL.
  • RNA-sequencing and survival analysis on a prospective T-ALL cohort (n=20).
  • Validation of candidate genes using external datasets (e.g., TARGET) and Kaplan-Meier survival analysis.

Main Results:

  • Six T-ALL-specific genes with prognostic value were identified by integrating DEGs and survival-related genes.
  • Expression levels of SLC40A1 and TES were independently validated as significant predictors of survival in both external and prospective T-ALL cohorts.

Conclusions:

  • TES and SLC40A1 gene expression levels demonstrate potential as predictive biomarkers for T-ALL patient survival.
  • These findings may contribute to improved risk stratification and personalized treatment approaches for T-ALL.